Accidental intoxication with methylene dianiline p,p '-Diaminodiphenylmethane: Acute liver damage after presumed ecstasy consumption

Journal of Toxicology - Clinical Toxicology

Volumn 35, Issue 1, 1997, Pages 35-40

  Tillmann, Hans L ^a   Van Pelt, Frank N A M ^a   Martz, Walter ^a   Luecke, Thomas ^a   Welp, Hartmut ^b   Dörries, Frauke ^b   Veuskens, Ansgar ^b   Fischer, Martin ^b   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Medizinische Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4,4' METHYLENEDIANILINE; ANILINE DERIVATIVE;

ABDOMINAL PAIN; ACCIDENT; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INTOXICATION; LIVER INJURY; LIVER TOXICITY; MALE; SYMPTOMATOLOGY; TOXICOLOGY;

EID: 0031041497     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659709001163     Document Type: Article

References (31)

1. 4,4′-Methylenedianiline and its dihydrochloride. IARC Monogr Eval Carcinog Risk Chem Hum 1986;39:347-365.
2. Fukushima S, Shibata M, Hibino T, Yoshimura T, Hirose M, Ito N. Intrahepatic bile duct proliferation induced by 4,4′-diaminodiphenylmethane in rats. Toxicol Appl Pharmacol 1979;48:145-155.
3. Beard RR, Noe JT. Aromatic nitro and amine compounds. In: Patty's Industrial Hygiene and Toxicology. Clayton GD, Clayton FE, eds., New York: John Wiley & Sons, 1981:2413-2489.
4. McQueen CA, Williams GM. Review of the genotoxicity and carcinogenicity of 4,4′-methylenedianiline and 4,4′-methylene-bis-2-chloroaniline. Mutat Res 1990;239:133-142.
5. Parodi S, Taningher M, Russo P, Pala M, Tamaro M, Monti Bragadin C. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen aromatic amines and azo-derivatives, as related quantitatively to their carcinogenicity. Carcinogenesis 1981;2:1317-1326.
6. Schoental R. Carcinogenic and chronic effects of 4,4′-diaminodiphenylmethane, an epoxyresin hardener. Nature 1968;219:1162-1163.
7. Liss GM, Guirguis SS. Follow-up of a group of workers intoxicated with 4,4′-methylenedianiline. Am J Ind Med 1994;26:117-124.
8. Selden A, Berg P, Jakobsson R, de Laval J. Methylene dianiline: assessment of exposure and cancer morbidity in power generator workers. Int Arch Occup Environ Health 1992;63:403-408.
9. Bastian PG. Occupational hepatitis caused by methylenedianiline. Med J Aust 1984;141:533-535.
10. LeVine MJ. Occupational photosensitivity to diamino-diphenylmethane. Contact Dermatitis 1983;9:488-490.
11. McGill DB, Motto JD. An industrial outbreak of toxic hepatitis due to methylenedianiline. N Engl J Med 1974;291:278-282.
12. Leong BK, Lund JE, Groehn JA, et al. Retinopathy from inhaling 4,4′-methylenedianiline aerosols. Fundam Appl Toxicol 1987;9:645-658.
13. Van Joost T, Heule F, de Boer J. Sensitization to methylenedianiline and para-structures. Contact Dermatitis 1987;16:246-248.
14. Roy CW, McSorley PD, Syme IG. Methylene dianiline: a new toxic cause of visual failure with hepatitis. Hum Toxicol 1985;4:61-66.
15. Kopelman H, Scheuer PJ, Williams R. The liver lesion of the Epping Jaundice, Q J Med 1966;35:553-564.
16. Kopelman H, Robertson MH, Sanders PG, Ash I. The Epping Jaundice. Br Med J 1966;1:514-516.
17. de Man RA. [Morbidity and mortality caused by use of ecstasy]. Ned Tijdschr Geneeskd 1994;138:1850-1855.
18. Forrest AR, Galloway JH, Marsh ID, Strachan GA, Clark JC. A fatal overdose with 3,4-methylenedioxyamphetamine derivatives. Forensic Sci Int 1994;64:57-59.
19. Walsh T, Carmichael R, Chestnut J. A hyperthermic reaction to 'ecstasy'. Br J Hosp Med 1994;51:476.
20. Barrett PJ, Taylor GT. 'Ecstasy' ingestion: a case report of severe complications. J R Soc Med 1993;86:233-234.
21. Fahal IH, Sallomi DF, Yaqoob M, Bell GM. Acute renal failure after ecstasy. BMJ 1992;305:29.
22. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 1992;340:384-387.
23. Jones AL, Jarvie DR, McDermid G, Proudfoot AT. Hepatocellular damage following amphetamine intoxication. J Toxicol Gin Toxicol 1994;32:435-444.
24. Tillmann HL, van Pelt FNAM, choefl C, Wagner S, Maschek H, Manns MP. Severe hepatitis and prolonged cholestasis following repeated ingestion of ecstasy. X. International Liver symposium. Acute and chronic liver disease. Molecular biology and clinic. Basel 1995; Abstrakt 267.
25. Fairbanks W. Blue gods, blue oil, and blue people. Mayo Clin Proc 1994;69:889-892.
26. Bailie MB, Hewett JA, Schultze AE, Roth RA. Methylene dianiline hepatotoxicity is not leukocyte-dependent. Toxicol Appl Pharmacol 1994;124:25-30.
27. Kanz MF, Kaphalia L, Kaphalia BS, Romagnoli E, Ansari GA. Methylene dianiline: Acute toxicity and effects on biliary function. Toxicol Appl Pharmacol 1992;117:88-97.
28. Cocker J, Nutley BP, Wilson HK. A biological monitoring assessment of exposure to methylene dianiline in manufactures and users. Occup Environ Med 1994;51:519-522.
29. de Man RA, Wilson JHP, Tjen HSLM. [Acute liver failure due to methylenedioxymethamphetamine (ecstasy)]. Ned Tijdschr Geneeskd 1993;137:727-729.
30. Lamb JC, Huff JE, Haseman JK, Murthy ASK, Lilja H. Carcinogenesis studies of 4,4′-methylenedianiline dihydrochloride given in drinking water to F344/N rats and B6C3F1 mice. J Toxicol Environ Health 1986;18:325-337.
31. Brunmark P, Brunze M, Skerfving S, Skarping G. Biomonitoring of 4,4′-methylene dianiline by measurement in hydrolysed urine and plasma after epicutaneous exposure in humans. Int Arch Occup Environ Health 1995;67:95-100.